SCHEMBL8344019

SCHEMBL8344019

Cc1onc(-c2ccccc2)c1-c1ccc(S(=O)(=O)OC(=O)CN)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 15/20 0.63
▸ PTGS1 P23219 4/20 0.63
▸ MT-CO2 P00403 3/20 0.63
▸ CA12 O43570 1/20 0.63
▸ CA1 P00915 1/20 0.63
▸ CA2 P00918 1/20 0.63
▸ LMNA P02545 1/20 0.63
▸ CA3 P07451 1/20 0.63
▸ ADRB2 P07550 1/20 0.63
▸ ADRB1 P08588 1/20 0.63
▸ CYP3A4 P08684 1/20 0.63
▸ ADORA3 P0DMS8 1/20 0.63
▸ CHRM1 P11229 1/20 0.63
▸ ADRA2B P18089 1/20 0.63
▸ CA4 P22748 1/20 0.63
▸ CA6 P23280 1/20 0.63
▸ SLC6A2 P23975 1/20 0.63
▸ PDE4A P27815 1/20 0.63
▸ ADORA1 P30542 1/20 0.63
▸ CA5A P35218 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8351119 0.89 PTGS2 (0.69) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL28370009 0.81 PTGS2 (0.71) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL28053565 0.80 PTGS2 (0.67) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL5071025 0.80 PTGS2 (0.82) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL6023713 0.79 PTGS2 (0.65) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL12103408 0.79 PTGS2 (0.62) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL6013897 0.78 PTGS2 (0.76) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL6168344 0.78 PTGS2 (1.00) PTGS2PTGS1MT-CO2CA12CA1
Valdecoxib SCHEMBL3356 0.78 PTGS2 (1.00) PTGS2PTGS1MT-CO2CA12CA1
Valdecoxib SCHEMBL3853130 0.78 PTGS2 (1.00) PTGS2PTGS1MT-CO2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5932598-A NOVEL SUBSTITUTED SULFONAMIDE COMPOUNDS USEFUL AS PRODRUGS; ADMINISTERING TO TREAT INFLAMMATION-ASSOCIATED PAIN DUE TO CANCER, DENTAL PAIN; CYCLOOXYGENASE-2 INHIBITORS G. D. SEARLE & CO. (US) 1999-08-03 — — US disclosed
Send feedback